BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38168163)

  • 1. Sex Differences and Role of Lysyl Oxidase Like 2 (LOXL2) in Angiotensin II-Induced Hypertension in Mice.
    Santhanam L; Wang H; Yus MM; Brady T; Choi R; Nandakumar K; Smith L; Jang R; Wodu BP; Almodiel JD; Stoddart L; Kim DH; Steppan J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38168163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysyl oxidase-like 2 depletion is protective in age-associated vascular stiffening.
    Steppan J; Wang H; Bergman Y; Rauer MJ; Tan S; Jandu S; Nandakumar K; Barreto-Ortiz S; Cole RN; Boronina TN; Zhu W; Halushka MK; An SS; Berkowitz DE; Santhanam L
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H49-H59. PubMed ID: 31002285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness.
    Eberson LS; Sanchez PA; Majeed BA; Tawinwung S; Secomb TW; Larson DF
    PLoS One; 2015; 10(4):e0124013. PubMed ID: 25875748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
    Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
    J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.
    Steppan J; Wang H; Nandakumar K; Poe A; Pak L; Brady T; Gadkari M; Berkowitz DE; Shimoda LA; Santhanam L
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of vascular thromboxane A
    Braun H; Hauke M; Petermann M; Eckenstaler R; Ripperger A; Schwedhelm E; Ludwig-Kraus B; Bernhard Kraus F; Jalal Ahmed Shawon M; Dubourg V; Zernecke A; Schreier B; Gekle M; Benndorf RA
    Biochem Pharmacol; 2024 Jan; 219():115916. PubMed ID: 37979705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-204 regulates type 1 IP
    Gabani M; Liu J; Ait-Aissa K; Koval O; Kim YR; Castañeda D; Vikram A; Jacobs JS; Grumbach I; Trebak M; Irani K; Kassan M
    Cell Calcium; 2019 Jun; 80():18-24. PubMed ID: 30925290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Axl in target organ inflammation and damage due to hypertensive aortic remodeling.
    Chen W; Van Beusecum JP; Xiao L; Patrick DM; Ao M; Zhao S; Lopez MG; Billings FT; Cavinato C; Caulk AW; Humphrey JD; Harrison DG
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H917-H933. PubMed ID: 36083796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension.
    Zhou N; Lee JJ; Stoll S; Ma B; Wiener R; Wang C; Costa KD; Qiu H
    Cardiovasc Res; 2017 Feb; 113(2):171-182. PubMed ID: 28003268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.
    Xiang R; Chen J; Li S; Yan H; Meng Y; Cai J; Cui Q; Yang Y; Xu M; Geng B; Yang J
    Circ Res; 2020 Jun; 126(12):1746-1759. PubMed ID: 32279581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor.
    DuPont JJ; Kim SK; Kenney RM; Jaffe IZ
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H169-H180. PubMed ID: 33095647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overexpression of human EP4 receptor in vascular smooth muscle cells attenuates angiotensin II-induced hypertension in mice].
    Xu H; Wang SL; Bao CZ; Ye L; Guan YF; Zhang XY
    Sheng Li Xue Bao; 2021 Aug; 73(4):597-605. PubMed ID: 34405216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular smooth muscle cells direct extracellular dysregulation in aortic stiffening of hypertensive rats.
    Hays TT; Ma B; Zhou N; Stoll S; Pearce WJ; Qiu H
    Aging Cell; 2018 Jun; 17(3):e12748. PubMed ID: 29603864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
    Hernanz R; Martínez-Revelles S; Palacios R; Martín A; Cachofeiro V; Aguado A; García-Redondo L; Barrús MT; de Batista PR; Briones AM; Salaices M; Alonso MJ
    Br J Pharmacol; 2015 Jun; 172(12):3159-76. PubMed ID: 25712370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MFAP4-Deficiency Aggravates Age-Induced Changes in Resistance Artery Structure, While Ameliorating Hypertension.
    Christensen KB; Ünsal Ş; Ebbesen MF; Hemstra L; Schlosser A; Rosenstand K; Hansen PBL; Jensen BL; Bloksgaard M; Simonsen U; Sorensen GL
    Hypertension; 2024 Jun; 81(6):1308-1319. PubMed ID: 38563153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
    Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
    FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin expression deficiency in mice contributes to vascular stiffening by extracellular matrix remodeling of the aortic wall.
    Romier B; Dray C; Vanalderwiert L; Wahart A; Hocine T; Dortignac A; Garbar C; Garbar C; Boulagnon C; Bouland N; Maurice P; Bennasroune A; Sartelet H; Martiny L; Duca L; Valet P; Blaise S
    Sci Rep; 2021 Nov; 11(1):22278. PubMed ID: 34782679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-derived extracellular microRNA-92a promotes arterial stiffness by regulating phenotype changes of vascular smooth muscle cells.
    Wang C; Wu H; Xing Y; Ye Y; He F; Yin Q; Li Y; Shang F; Shyy JY; Yuan ZY
    Sci Rep; 2022 Jan; 12(1):344. PubMed ID: 35013491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of lysyl oxidase in the pathogenesis of arterial stiffness in chronic kidney disease.
    Sharma RK; Kamble SH; Krishnan S; Gomes J; To B; Li S; Liu IC; Gumz ML; Mohandas R
    Am J Physiol Renal Physiol; 2023 Apr; 324(4):F364-F373. PubMed ID: 36825626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring Blood Pressure in Hypertensive Mice Fails to Fully Reverse Vascular Stiffness.
    Steppan J; Jandu S; Savage W; Wang H; Kang S; Narayanan R; Nyhan D; Santhanam L
    Front Physiol; 2020; 11():824. PubMed ID: 32792976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.